BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gogtay M, Singh Y, Bullappa A, Scott J. Retrospective analysis of aspirin's role in the severity of COVID-19 pneumonia. World J Crit Care Med 2022; 11(2): 92-101 [PMID: 35433312 DOI: 10.5492/wjccm.v11.i2.92]
URL: https://www.wjgnet.com/2220-3141/full/v11/i2/92.htm
Number Citing Articles
1
Wanting Su, He Miao, Zhaotian Guo, Qianhui Chen, Tao Huang, Renyu Ding. Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysisFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.989903
2
Melek Cihanbeylerden, Ozge Can Bostan, Gulseren Tuncay, Cagla Safak, Ebru Damadoglu, Gul Karakaya, Ali Fuat Kalyoncu. Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway diseaseAllergy and Asthma Proceedings 2023; 44(4): e3 doi: 10.2500/aap.2023.44.230021
3
Ángela Prieto-Campo, Maruxa Zapata-Cachafeiro, Manuel Portela-Romero, María Piñeiro-Lamas, Adolfo Figueiras, Ángel Salgado-Barreira. Impact of prior use of antiplatelets on COVID-19 susceptibility, progression, and severity: a population-based studyRevista Española de Cardiología (English Edition) 2024;  doi: 10.1016/j.rec.2023.12.004
4
Ángela Prieto-Campo, Maruxa Zapata-Cachafeiro, Manuel Portela-Romero, María Piñeiro-Lamas, Adolfo Figueiras, Ángel Salgado-Barreira. Impacto del uso previo de antiagregantes plaquetarios en la susceptibilidad, la progresión y la gravedad de la COVID-19: un estudio poblacionalRevista Española de Cardiología 2024;  doi: 10.1016/j.recesp.2023.12.012